In a Different Vein: News From the Blood Journals Portfolio

Recent research from ASH’s Blood journals

For articles on research from Blood and Blood Advances published prior to May 2024, visit Written in Blood and Blood Advances in a Different Vein.

Relapse-Free Survival Progressively Shortens in Black Patients With Rituximab-Treated iTTP

Katie Robinson

Danicopan Plus Ravulizumab, Eculizumab Shows Long-Term Efficacy in PNH With Clinically Significant EVH

Katie Robinson

Combination of Venetoclax, Lower Intensity CPX-351 Shows Positive Results in Early-Stage AML Study

Anna Azvolinsky, PhD

EMD Lesions Comprise Multicellular Ecosystems With New Therapeutic Avenues

Katie Robinson

Anxiety, Depression Elevated in Patients with Histiocytic Neoplasms

Lara C. Pullen, PhD

Daratumumab Plus Lenalidomide Combination Improves Conversion to MRD-Negative Status in Post-Transplant Patients With Multiple Myeloma

Anna Azvolinsky, PhD

ASH Recruitment Program Boosts Representation in Hematology Field, Study Shows

Anna Azvolinsky, PhD

BOVen Regimen NCCN-Approved Option for TP53-Mutated MCL

Leah Lawrence

Weekly Low-Dose Regimen of Decitabine and Venetoclax as Effective as Higher Dose

Lara C. Pullen, PhD

Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Respond Well to Asciminib, Dasatinib

Lara C. Pullen, PhD

Soluble Anti-B-Cell Maturation Antigen, High Disease Burden Modulate Responses in Patients With MM Receiving BCMA T-Cell–Engager Therapy

Lara C. Pullen, PhD

Experts Release Guidance on Liver-Related Toxicities With Gene Therapy for Hemophilia A

Anna Azvolinsky, PhD

Venetoclax Effective for Bridging to Transplant in R/R AML, Study Suggests

Thomas R. Collins

New Therapy May Be Effective for Patients With Cold Agglutinin Disease, Warm Antibody Autoimmune Hemolytic Anemia

Anna Azvolinsky, PhD

Genetics-Based Risk Model to Stratify Survival Outcomes of Patients With AML Treated With Venetoclax-Azacitidine

Anna Azvolinsky, PhD

Better Preventive Stroke Management Needed for SCD

Ruth Jessen Hickman, MD

Pediatric T-LBL But Not T-ALL Harbors TRB::NOTCH1 Fusions With Increased Relapse Risk

Katie Robinson

SCD Gene Therapies Present Major Challenges to State Medicaid Budgets

Ruth Jessen Hickman, MD

Teclistamab Elicits Responses in Patients With Multiple Myeloma Previously Treated With BCMA-Targeted Therapy

Anna Azvolinsky, PhD

Fixed-Duration Regimen Safe, Effective for CLL

Lara C. Pullen, PhD

1 2 3

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
February 2025

Advertisement intended for health care professionals

In a Different Vein: News From the Blood Journals Portfolio

ASH Publications

American Society of Hematology

In a Different Vein: News From the Blood Journals Portfolio

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only